We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.95B
AUM Growth
-$1.81B
Cap. Flow
-$2.26B
Cap. Flow %
-57.22%
Top 10 Hldgs %
20.19%
Holding
2,722
New
659
Increased
534
Reduced
781
Closed
710

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$27.1M
2
XYZ
Block Inc
XYZ
+$21.9M
3
ORCL icon
Oracle
ORCL
+$20.5M
4
CVNA icon
Carvana
CVNA
+$20.4M
5
ETSY icon
Etsy
ETSY
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 9.34%
2 Financials 8.45%
3 Industrials 8.01%
4 Consumer Discretionary 7.89%
5 Healthcare 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNET
2651
DELISTED
RigNet, Inc.
RNET
-84,896
Closed -$183K
RP
2652
DELISTED
RealPage, Inc.
RP
-12,229
Closed -$795K
IPHI
2653
DELISTED
INPHI CORPORATION
IPHI
-166,499
Closed -$19.6M
PS
2654
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
-57,253
Closed -$1.03M
HPR
2655
DELISTED
HighPoint Resources Corporation
HPR
-12,513
Closed -$185K
GEN
2656
DELISTED
Genesis Healthcare, Inc.
GEN
-200,900
Closed -$139K
ZAGG
2657
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
-67,066
Closed -$211K
EIDX
2658
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
-4,359
Closed -$207K
ARA
2659
DELISTED
American Renal Associates Holdings, Inc
ARA
-10,900
Closed -$71K
CXO
2660
CALL
DELISTED
CONCHO RESOURCES INC.
CXO
-4,200
Closed -$216K
BMY.RT
2661
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-2,193
Closed -$8K
DNKN
2662
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-32,037
Closed -$2.09M
YGYI
2663
DELISTED
Youngevity International, Inc Common Stock
YGYI
-20,650
Closed -$30K
MYOK
2664
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-10,239
Closed -$989K
AMAG
2665
DELISTED
AMAG Pharmaceuticals
AMAG
-18,215
Closed -$139K
CBL
2666
DELISTED
CBL& Associates Properties, Inc.
CBL
-987,371
Closed -$269K
AXAS
2667
DELISTED
Abraxas Petroleum Corp
AXAS
-44,512
Closed -$208K
ONDK
2668
DELISTED
On Deck Capital, Inc.
ONDK
-135,350
Closed -$97K
AMTD
2669
DELISTED
TD Ameritrade Holding Corp
AMTD
-23,067
Closed -$839K
GMO
2670
DELISTED
General Moly, Inc.
GMO
-26,659
Closed -$5K
WUBA
2671
DELISTED
58.com Inc
WUBA
-78,476
Closed -$4.23M
LOGM
2672
DELISTED
LogMein, Inc.
LOGM
-85,806
Closed -$7.27M
VAL
2673
CALL
DELISTED
Valaris plc Class A Ordinary Share
VAL
-10,000
Closed -$7K
FSCT
2674
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
-215,585
Closed -$4.57M
CHAP
2675
DELISTED
Chaparral Energy, Inc.
CHAP
-2,500,000
Closed -$1.62M

Similar funds

Paloma Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Paloma Partners held 2,722 positions worth $3.95B, down 31% from $5.76B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Paloma Partners withdrew a net $2.26B in Q3 2020, closing 710 positions and reducing 781 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $21.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 11% a quarter earlier, followed by Financials and Industrials.

Against the trend, Paloma Partners opened a new position in Just Eat Takeaway.com N.V. American Depositary Shares worth $11.4M.

  • Paloma Partners's largest Q3 2020 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 78,494 shares worth $11.4M.
  • Paloma Partners added most to Eli Lilly in Q3 2020, an estimated $27.1M increase.
  • Paloma Partners's biggest Q3 2020 reduction was iShares US Real Estate ETF, cutting an estimated $86.8M.
  • Paloma Partners fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2020, selling an estimated $21.5M.
  • Paloma Partners's ten largest holdings make up 20% of its $3.95B portfolio in Q3 2020.
  • Paloma Partners opened 659 new positions and closed 710 in Q3 2020.
  • Paloma Partners's portfolio value fell 31% quarter-over-quarter to $3.95B.

Based on Paloma Partners's 13F filing for Q3 2020, filed 16 Nov 2020.